Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 146

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 146
---
6, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” If the Company Shares are listed on Nasdaq, they will be covered securities; however, if the Company Shares cease to be listed, our securities will not be covered securities and we would be subject to regulation in each state in which we offer our securities. Certain recent public offerings of companies with public floats comparable to the Company public float have experienced extreme volatility that was seemingly unrelated to the underlying performance of the respective company. The Company may experience similar volatility, which may make it difficult for prospective investors to assess the value of the Company Shares. The Company Shares may be subject to extreme volatility that is seemingly unrelated to the underlying performance of our business. Recently, companies with comparable public floats and initial public offering sizes have experienced instances of extreme stock price run -upsfollowed by rapid price declines, and such stock price volatility was seemingly unrelated to the respective company’s underlying performance. Although the specific cause of such volatility is unclear, our public float may amplify the impact of the actions taken by a few shareholders on the price of Company Shares, which may cause our share price to deviate, potentially significantly, from a price that better reflects the underlying performance of our business. Should the Company Shares experience run -upsand declines that are seemingly unrelated to the Company’s actual or expected operating performance and financial condition or prospects, prospective investors may have difficulty assessing the rapidly changing value of Company Shares. In addition, investors in Company Shares may experience losses, which may be material, if the price of Company Shares declines after the Closing or if such investors purchase ordinary shares prior to any price decline. A provision of the SPAC Warrant Agreement could cause the downward adjustment of the exercise price for the Company Warrants in connection with the Transaction, which could lead to further dilution for holders of Company Shares. If (i) we issue additional Company Shares or equity -linkedsecurities for capital raising purposes in connection with the closing of the Business Combination at a newly issued price of less than $9.20 per Company Share, (ii) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Business Combination on the date of the consummation of the Business Combination (net of redemptions), and (iii) the market value of Company Shares is below $9.20 per share, then the exercise price of the Company